Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$616M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$239M |
| 3 |
DuPont de Nemours
DD
|
+$227M |
| 4 |
AbbVie
ABBV
|
+$223M |
| 5 |
General Motors
GM
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$299M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$229M |
| 4 |
BP
BP
|
+$216M |
| 5 |
Air Products & Chemicals
APD
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.84% |
| 2 | Energy | 10.94% |
| 3 | Miscellaneous | 8.86% |
| 4 | Technology | 8.76% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SVU
2976
DELISTED
SUPERVALU Inc.
SVU
| $102K | ﹤0.01% |
4,693
+2,548
| +119% | +$56.4K |
2013 Q2
17 quarters
|
|
2977
Cass Information Systems
CASS
$688M
| $101K | ﹤0.01% |
2,094
+156
| +8% | +$7.44K |
2013 Q2
17 quarters
|
|
2978
Prestige Consumer Healthcare
PBH
$2.12B
| $100K | ﹤0.01% |
2,008
-6,664
| -77% | -$340K |
2013 Q2
17 quarters
|
|
2979
UFP Technologies
UFPT
$2.28B
| $100K | ﹤0.01% |
+3,534
| New | +$97.7K |
2017 Q3
0 quarters
|
|
|
WBB
2980
DELISTED
Westbury Bancorp, Inc.
WBB
| $100K | ﹤0.01% |
5,000
| – | – |
2013 Q2
17 quarters
|
|
2981
Rockwell Medical
RMTI
$34.5M
| $99K | ﹤0.01% |
105
| – | – |
2014 Q4
11 quarters
|
|
|
2982
PUT
Rockwell Medical
RMTI
$34.5M
| $99K | ﹤0.01% |
105
| – | – |
2016 Q1
6 quarters
|
|
|
ITCI
2983
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $99K | ﹤0.01% |
6,324
-152
| -2% | -$2.23K |
2015 Q3
8 quarters
|
|
|
HYLD
2984
DELISTED
High Yield ETF
HYLD
| $99K | ﹤0.01% |
2,740
| – | – |
2014 Q1
14 quarters
|
|
|
BMTC
2985
DELISTED
Bryn Mawr Bank Corp
BMTC
| $99K | ﹤0.01% |
2,251
-2,017
| -47% | -$84.1K |
2013 Q4
15 quarters
|
|
2986
Cimpress
CMPR
$1.83B
| $98K | ﹤0.01% |
1,005
-25
| -2% | -$2.32K |
2014 Q4
11 quarters
|
|
2987
Veritone
VERI
$75.3M
| $98K | ﹤0.01% |
2,161
+1,509
| +231% | +$28K |
2017 Q2
1 quarter
|
|
|
CCXI
2988
DELISTED
ChemoCentryx, Inc.
CCXI
| $98K | ﹤0.01% |
13,132
+2,138
| +19% | +$17.8K |
2017 Q2
1 quarter
|
|
2989
Viavi Solutions
VIAV
$11B
| $97K | ﹤0.01% |
10,230
-11
| -0.1% | -$115 |
2013 Q2
17 quarters
|
|
|
TBRG
2990
DELISTED
TruBridge
TBRG
| $97K | ﹤0.01% |
3,281
| – | – |
2017 Q1
2 quarters
|
|
|
GSV
2991
DELISTED
Gold Standard Ventures Corp.
GSV
| $97K | ﹤0.01% |
60,000
| – | – |
2016 Q1
6 quarters
|
|
|
MDP
2992
DELISTED
Meredith Corporation
MDP
| $97K | ﹤0.01% |
1,752
+38
| +2% | +$2.15K |
2013 Q2
17 quarters
|
|
|
LPNT
2993
DELISTED
LifePoint Health, Inc.
LPNT
| $97K | ﹤0.01% |
1,687
-217
| -11% | -$12.9K |
2013 Q2
17 quarters
|
|
2994
ESCO Technologies
ESE
$6.99B
| $96K | ﹤0.01% |
1,611
| – | – |
2015 Q2
9 quarters
|
|
2995
Powell Industries
POWL
$6.94B
| $96K | ﹤0.01% |
9,606
| – | – |
2013 Q2
17 quarters
|
|
2996
Simply Good Foods
SMPL
$874M
| $96K | ﹤0.01% |
+8,200
| New | +$97.1K |
2017 Q3
0 quarters
|
|
|
ALEX
2997
DELISTED
Alexander & Baldwin
ALEX
| $95K | ﹤0.01% |
2,062
-50
| -2% | -$2.16K |
2013 Q2
17 quarters
|
|
|
HTD
2998
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$785M
| $95K | ﹤0.01% |
3,662
-500
| -12% | -$12.8K |
2015 Q3
8 quarters
|
|
2999
Ollie's Bargain Outlet
OLLI
$5.22B
| $95K | ﹤0.01% |
2,035
+185
| +10% | +$8.17K |
2015 Q3
8 quarters
|
|
3000
Schwab US Large-Cap Growth ETF
SCHG
$63.8B
| $95K | ﹤0.01% |
11,544
| – | – |
2014 Q2
13 quarters
|
|
Similar funds
Bank of Montreal's Q3 2017 Portfolio in Review
As of Q3 2017, Bank of Montreal held 4,520 positions worth $109B, up 4.7% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of Montreal's Q3 2017 filing shows 258 new, 1,597 increased, 1,464 reduced and 295 closed positions. Its largest new stake was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M. The largest sale was Mondelez International, an estimated $299M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q3 2017 buy was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M.
- Bank of Montreal added most to Altaba Inc in Q3 2017, an estimated $616M increase.
- Bank of Montreal's biggest Q3 2017 reduction was Mondelez International, cutting an estimated $299M.
- Bank of Montreal fully exited Reynolds American Inc in Q3 2017, selling an estimated $229M.
- Bank of Montreal's ten largest holdings make up 21% of its $109B portfolio in Q3 2017.
- Bank of Montreal opened 258 new positions and closed 295 in Q3 2017.
- Bank of Montreal's portfolio value rose 4.7% quarter-over-quarter to $109B.
Based on Bank of Montreal's 13F filing for Q3 2017, filed 16 Oct 2017.